Genfit S.A. Files 6-K, Incorporates into Registration Statements
| Field | Detail |
|---|---|
| Company | Genfit S.A. |
| Form Type | 6-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, registration-statement, foreign-private-issuer
TL;DR
Genfit filed a 6-K on 5/22/25, linking it to existing F-3 and S-8 filings.
AI Summary
Genfit S.A. filed a Form 6-K on May 22, 2025, incorporating information into its existing registration statements on Form F-3 (File No. 333-271312) and Form S-8 (File No. 333-271311). This filing is a report of a foreign private issuer pursuant to SEC rules.
Why It Matters
This filing indicates Genfit is updating its public disclosures and potentially making its information more readily available for future offerings or employee stock plans, as referenced by the incorporation into Form F-3 and S-8.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not appear to contain new material financial or operational information.
Key Players & Entities
- Genfit S.A. (company) — Registrant
- May 22, 2025 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form F-3 (document) — Incorporated Registration Statement
- 333-271312 (document_id) — Form F-3 File Number
- Form S-8 (document) — Incorporated Registration Statement
- 333-271311 (document_id) — Form S-8 File Number
FAQ
What is the purpose of incorporating this 6-K filing into Genfit's existing registration statements?
The filing states that the contents of this Form 6-K are incorporated by reference into Genfit's registration statements on Form F-3 (File No. 333-271312) and Form S-8 (File No. 333-271311), suggesting it's to update or supplement information relevant to those statements, which are used for public offerings and employee stock plans.
What type of company is Genfit S.A. according to the filing?
Genfit S.A. is identified as a 'Foreign Private Issuer' and its Standard Industrial Classification is 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
When was this Form 6-K filed with the SEC?
The Form 6-K was filed on May 22, 2025.
What is the principal executive office address for Genfit S.A.?
The principal executive office is located at Parc Eurasanté, 885, avenue Eugéne Avinèe, 59120 Loos, France.
Does Genfit file annual reports under Form 20-F or Form 40-F?
The filing indicates with a checkmark that Genfit files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 22, 2025 regarding Genfit S.A..